Eilien Heinrich

Eilien Heinrich

Auto-generated profile, based on publicly available information

Eilien Heinrich

Fraunhofer Institute for Microengineering and Microsystems IMM, Carl-Zeiss-Str. 18-20, 55129 Mainz, Germany

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2020 in Cells
Verified
Journal Article
Open access
PDF file
Adriely GoesAdriely Goes
Adriely Goes
PLPhilipp Lapuhs
Philipp Lapuhs
TKThomas Kuhn
Thomas Kuhn
ESEilien Schulz
Eilien Schulz
RRRobert Richter
Robert Richter
GFGregor Fuhrmann
Gregor Fuhrmann
In 2019, it was estimated that 2.5 million people die from lower tract respiratory infections annually. One of the main causes of these infections is Staphylococcus aureus, a bacterium that can invade and survive within mammalian cells. S. aureus intracellular infections are difficult to treat because several classes of antibiotics are unable to permeate through the cell wall and reach the pathogen. This condition increases the need for new therapeutic avenues, able to deliver antibiotics efficiently. In this work, we obtained outer membrane vesicles (OMVs) derived from the myxobacteria Cystobacter velatus strain Cbv34 and Cystobacter ferrugineus strain Cbfe23, that are naturally antimicrobial, to target intracellular infections, and investigated how they can affect the viability of epithelial and macrophage cell lines. We evaluated by cytometric bead array whether they induce the expression of proinflammatory cytokines in blood immune cells. Using confocal laser scanning microscopy and flow cytometry, we also investigated their interaction and uptake into mammalian cells. Finally, we studied the effect of OMVs on planktonic and intracellular S. aureus. We found that while Cbv34 OMVs were not cytotoxic to cells at any concentration tested, Cbfe23 OMVs affected the viability of macrophages, leading to a 50% decrease at a concentration of 125,000 OMVs/cell. We observed only little to moderate stimulation of release of TNF-alpha, IL-8, IL-6 and IL-1beta by both OMVs. Cbfe23 OMVs have better interaction with the cells than Cbv34 OMVs, being taken up faster by them, but both seem to remain mostly on the cell surface after 24 h of incubation. This, however, did not impair their bacteriostatic activity against intracellular S. aureus. In this study, we provide an important basis for implementing OMVs in the treatment of intracellular infections.

20 March 2023 in Small
Verified
Journal Article
Open access
EHEilien Heinrich
Eilien Heinrich
OHOlga Hartwig
Olga Hartwig
CWChristine Walt
Christine Walt
AKArefeh Kardani
Arefeh Kardani
MKMarcus Koch
Marcus Koch
GFGregor Fuhrmann
Gregor Fuhrmann
Recently, extracellular vesicles (EVs) sparked substantial therapeutic interest, particularly due to their ability to mediate targeted transport between tissues and cells. Yet, EVs’ technological translation as therapeutics strongly depends on better biocompatibility assessments in more complex models and elementary in vitro–in vivo correlation, and comparison of mammalian versus bacterial vesicles. With this in mind, two new types of EVs derived from human B‐lymphoid cells with low immunogenicity and from non‐pathogenic myxobacteria SBSr073 are introduced here. A large‐scale isolation protocol to reduce plastic waste and cultivation space toward sustainable EV research is established. The biocompatibility of mammalian and bacterial EVs is comprehensively evaluated using cytokine release and endotoxin assays in vitro, and an in vivo zebrafish larvae model is applied. A complex three‐dimensional human cell culture model is used to understand the spatial distribution of vesicles in epithelial and immune cells and again used zebrafish larvae to study the biodistribution in vivo. Finally, vesicles are successfully loaded with the fluoroquinolone ciprofloxacin (CPX) and showed lower toxicity in zebrafish larvae than free CPX. The loaded vesicles are then tested effectively on enteropathogenic Shigella, whose infections are currently showing increasing resistance against available antibiotics.

16 August 2024 in RSC Advances
Verified
Journal Article
Open access
CWChristina Wenck
Christina Wenck
NMNils Meier
Nils Meier
EHEilien Heinrich
Eilien Heinrich
VGVerena Grützner
Verena Grützner
FWFrank Wiekhorst
Frank Wiekhorst
RBRegina Bleul
Regina Bleul
Magnetic protein-coated, drug-loaded nanohybrids have huge potential in future cancer theranostics for real-time monitored drug delivery.

17 November 2022 in Nanoscale
Verified
Journal Article
Closed access
PDF file
PLPhilipp Lapuhs
Philipp Lapuhs
EHEilien Heinrich
Eilien Heinrich
RGRonald Garcia
Ronald Garcia
Adriely GoesAdriely Goes
Adriely Goes
NFNicolas Frank
Nicolas Frank
GFGregor Fuhrmann
Gregor Fuhrmann
Outer membrane vesicles are small, lipid-based vesicles shed from the outer membrane of Gram-negative bacteria.